Stockreport

European Medicines Agency Accepts Astellas’ Marketing Authorization Application for Roxadustat

FibroGen, Inc  (FGEN) 
Last fibrogen, inc earnings: 3/2 04:01 pm Check Earnings Report
PDF TOKYO and SAN FRANCISCO, May 21, 2020 (GLOBE NEWSWIRE) -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and FibroGen, Inc. (Na [Read more]